Members News

2025-10-29 > All chapters

Boehringer Ingelheim’s JASCAYD® approved in China for the treatment of idiopathic pulmonary fibrosis (IPF)

In October, Boehringer Ingelheim’s innovative therapy for pulmonary fibrosis, JASCAYD® was officially approved by the National Medical Products Administration (NMPA) of China for the treatment of adult idiopathic pulmonary fibrosis (IPF).

Read more
2025-10-28 > All chapters

New Regulation on Chinese Government Procurement and the lmpact

On September 30, 2025, China issued the Notice on Implementing Domestic Product Standards in Government Procurement (Guobanfa [2025] No. 34), outlining evaluation mechanism adjustments.

Read more
2025-09-22 > All chapters

New Interpretation on Labor Laws: Voluntary Waiver of Social Insurance are Void

On September 1, 2025, the highly anticipated Interpretation (II) of the Supreme People’s Court on Several Issues Concerning the Application of Law in the Trial of Labor Dispute Cases officially came into effect.

Read more
2025-08-27 > All chapters

Analysis of the WTO’s Ruling on the China-EU Patent Dispute

The recent WTO arbitration decision on the China-EU dispute over anti-suit injunctions (ASIs) in standard essential patent (SEP) cases has drawn significant attention in international trade and intellectual property circles.

Read more
2025-07-28 > All chapters

Revision of the Unfair Competition Law: Interpretation and Impact

On June 27, 2025, the Chinese legislature passed the third amendment to the Anti-Unfair Competition Law, which will come into force on October 15th.

Read more
2025-06-06 > Beijing

A Fine Blend of Science with Heritage Grapevines to Future Proof Australian Wines

New climate resilient and mildew resistant grapevines have been planted in South Australia to help protect Australia’s $45 billion industry.

Read more
2025-06-06 > All chapters

Boehringer Ingelheim: Metalyse® successfully approved in China for the treatment of acute ischemic stroke

In May, Boehringer Ingelheim's innovative thrombolytic drug, Metalyse® (tenecteplase) has received approval from the National Medical Products Administration of China for the treatment of acute ischemic stroke (AIS) within 4.5 hours of symptom onset

Read more
2025-05-16 > All chapters

Applying Contract Avoidance of CISG in International Trade

In international trade, when a party commits a serious breach of contract, the United Nations Convention on Contracts for the International Sale of Goods provides a unique remedial mechanism for the injured party—avoidance of the contract.

Read more
2025-05-12 > All chapters

Winners of the 2024 Boehringer-PKU Researcher Award and Postdoctoral Fund Award officially announced

Boehringer Ingelheim and Peking University jointly announced the winners of the 2024 “Boehringer Ingelheim Researcher Awards” and “Postdoctoral Fund Awards.”

Read more